News | May 08, 2022
Lonza to sell processing plant in Quakertown, Pennsylvania
Upon closing, the Quakertown business will become an independent company called Microsize
Upon closing, the Quakertown business will become an independent company called Microsize
Both companies have been selected for stand-by production by German government
The new facility is scheduled to start operation in the first half of 2024
The company’s differentiated value proposition comes during a time of unprecedented disruption in the life science supply chain
Expected to open later this year, the facility will significantly increase distribution capacity to meet the growing demand for production materials by Ireland's biopharma industry
In the first phase of the Grangemouth site expansion, two new ADC manufacturing suites, operational by Q3 2023, will be added to the existing three
Aster DM Healthcare has reported consolidated financial results for the period ended December 31, 2021
The management guided for ARV API & formulation demand to be normalised from Q4FY22 and reiterated the aspiration of US $ 1 billion in sales by FY23: ICICI Direct
The biopharmaceutical market has been on a growth curve. India is number three in the Asia Pacific market. Gaurav Kaushik, MD & Director & CEO, Meteoric Biopharmaceuticals shares a perspective on the industry
The biopharmaceutical market has been on a growth curve. India is number three in the Asia Pacific market. Gaurav Kaushik, MD & CEO, Meteoric Biopharmaceuticals shares a perspective on the industry
Subscribe To Our Newsletter & Stay Updated
